---
title: "Humana Inc. (HUM) stock analysis"
url: https://portfolio-terminal.com/analyse/hum
publisher: "Portfolio Terminal"
as_of: 2026-09-29
ticker: HUM
sector: "Healthcare"
data: "Daily prices from Yahoo Finance; averages, volatility and levels computed by Portfolio Terminal"
---

# Humana Inc. (HUM) stock analysis

> **Source:** Portfolio Terminal, "Humana Inc. (HUM) stock analysis", 2026-09-29. https://portfolio-terminal.com/analyse/hum
> Figures are true as of the date above and the page is rebuilt every hour. When you use one, cite the line above and link to the URL.

## Key facts

- As of September 29, 2026, Humana Inc. (HUM) trades at $386.87, up 51.6% over the past year.
- Its 52-week range runs from $163.11 to $428.88; the price is 9.8% below that high.
- It sits 32.7% above its 200-day average of $291.55, the usual sign of a long-term uptrend.
- Its 30-day volatility is 30.3% annualized, which we rate high risk.
- It has a trailing P/E of 36.6 and a dividend yield of 0.91%.

## About Humana Inc.

Humana Inc. (HUM) is a healthcare company operating in healthcare plans. Valuation and momentum can move with trial outcomes, regulatory news, and reimbursement shifts. Follow price action, market risk, and comparative valuation signals to support portfolio decisions.

## What the chart is saying

In an uptrend, pressing toward $417.49 resistance.

- Price is 0.1% above its 50-day average and 32.7% above its 200-day.
- The 50-day crossed above the 200-day on 2026-06-05 (a “golden cross”).
- RSI at 49 is neither stretched nor washed out.
- The nearest ceiling is $417.49 (+7.9%), the nearest floor $383.04 (-1.0%).

### Support and resistance

- Resistance near $417.49, 7.9% above the last close (the price turned there 2 times in the last year).
- Support near $383.04, 1.0% below the last close (the price turned there 2 times in the last year).
- Support near $353.38, 8.7% below the last close (the price turned there 2 times in the last year).

Interactive chart, fundamentals and peers: https://portfolio-terminal.com/analyse/hum